Real-world pediatric diabetes technology adoption and integration after subsidization expansion: a Repeated Cross-Sectional Study
This repeated cross-sectional study in Hungary demonstrates that while expanding social security subsidies for diabetes technology since 2020 significantly increased CGM adoption among pediatric patients, it did not eliminate distinct self-management patterns or guarantee full technology integration, suggesting that financial access alone is insufficient to standardize therapeutic practices and decision-making cultures.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Living with type 1 diabetes means managing a condition where the body no longer produces insulin, the hormone needed to process sugar. Without careful daily attention, blood sugar levels can swing dangerously high or low, leading to immediate emergencies or long-term damage to the eyes, kidneys, and nerves. For decades, the standard approach involved checking blood sugar with a finger-prick test several times a day and administering insulin through injections. However, a new generation of tools has emerged to ease this burden. Continuous glucose monitors are small sensors worn on the skin that track sugar levels around the clock, sending the data to a receiver or phone. Insulin pumps are devices that deliver insulin continuously through a tiny tube, replacing the need for multiple daily injections. While these technologies promise better health and a more relaxed life, they have historically been expensive, creating a gap between those who can afford them and those who cannot.
In Hungary, a significant shift occurred in 2020 when the government expanded its social security support to cover these modern devices. Before this change, families could get help with insulin pumps, but the continuous glucose monitors had to be paid for out of pocket. The new policy made both devices virtually free for children under 18 and young adults in higher education up to age 24, removing the financial barrier that had kept many families from using them. This change offered researchers a rare opportunity to observe what happens when cost is no longer the deciding factor. A team of scientists from the University of Szeged set out to understand how this policy shift altered the daily lives of families managing pediatric diabetes. They wanted to know not just if more families bought the devices, but how they actually used them and whether the removal of financial hurdles changed the way parents made decisions about their children's care.
To find the answers, the researchers compared two snapshots of the same population taken at different times. They gathered data from parents of children with type 1 diabetes in 2018, before the funding reform, and again in 2025, after the new support had been in place for several years. They asked hundreds of parents about which devices they used, why they chose them, and what obstacles they faced. The results showed a dramatic transformation in how diabetes was managed. In 2018, fewer than half of the children used a continuous glucose monitor, and many still relied on traditional finger-prick tests. By 2025, the situation had flipped completely: more than 85 percent of the children were using the sensors, while the use of traditional blood glucose meters had dropped to just 15 percent. This massive shift suggests that when the price tag is removed, families overwhelmingly choose the technology that offers continuous monitoring.
The use of insulin pumps also grew, but the change was more modest. While the number of families using pumps rose from about 41 percent to 47 percent, the increase was not as explosive as the jump in sensor usage. The researchers found that simply making the devices free did not guarantee that every family would adopt the most advanced combination of tools. Instead, the data revealed that families fell into three distinct groups based on how they approached these technologies. The first group, which the researchers called "safety seekers," consisted mostly of parents of younger children. These families had embraced the continuous glucose monitors because they provided a constant stream of information that made them feel more secure, but they remained hesitant about using insulin pumps. They trusted the data from the sensors but were cautious about handing over control of insulin delivery to a machine.
A second group, labeled "hesitant adopters," included families with children across a wide age range. These parents used the sensors regularly and were beginning to interpret the data patterns, yet they still felt uncertain about adding a pump to their routine. For them, the decision was often a balance between the convenience of automation and the fear of losing control or facing technical problems. The third group, the "technology frontrunners," was made up largely of parents of teenagers. These families had fully integrated both the sensors and the pumps into their daily lives, viewing the combination as a single, cohesive system for managing their child's health. They were the most confident in the technology and the most likely to use the devices together to achieve the highest level of control.
The study highlighted that while money was a major barrier in the past, it was not the only one. Even with the devices being free, some families still chose not to use pumps because their children did not want to wear them, or because the parents feared technical failures. The research also showed that the way parents made decisions had evolved. In 2018, financial concerns were a primary reason for rejecting new technology. By 2025, those concerns had largely vanished, replaced by considerations about comfort, trust in the device's accuracy, and the preferences of the child. The influence of other parents and online communities had grown stronger, with many families citing the experiences of peers as a key factor in their choices.
Ultimately, the findings suggest that providing free access to medical technology is a powerful first step, but it does not automatically lead to universal adoption of the most advanced tools. The removal of financial barriers allowed the majority of families to access continuous glucose monitoring, which fundamentally changed how they tracked their children's health. However, the decision to use insulin pumps remained deeply personal, influenced by psychological factors, family dynamics, and the specific needs of the child. The researchers concluded that for technology to be fully integrated into a family's life, support systems must go beyond just paying the bill. They need to address the emotional and practical challenges of adaptation, helping families move from simply having the devices to confidently and comfortably using them as part of a sustainable, long-term strategy for health.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.